Axillary Reverse Mapping for Invasive Carcinoma of the Breast

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

Primary Objectives: * To determine the feasibility of axillary reverse mapping (ARM) in patients undergoing axillary lymph node dissection for breast cancer therapy. * To determine the incidence of breast cancer metastasis in lymph nodes draining in the arm as identified by axillary reverse mapping. * To determine the safety of axillary reverse mapping.

Key facts

Study ID

NCT00645541

Run by

M.D. Anderson Cancer Center

People needed

35

Starts

2008-03-01

Expected to finish

2010-11-01

Last updated by the study team

2012-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with invasive carcinoma of the breast planning to undergo axillary lymph node dissection at M. D. Anderson Cancer Center.
• Eastern Cooperative Oncology Group (ECOG) performance status of equal to or less than 3.

You may not qualify if…

• Patients with known allergies to blue dye or other contraindications to Lymphazurin.

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.